TY  - JOUR

T1  - EMA and NICE appraisal processes for cancer drugs: Current status and uncertainties

JO  - Applied Health Economics and Health Policy

UR  - https://eprints.whiterose.ac.uk/id/eprint/131844

PY  - 2018/08/01

AU  - Dickson R

AU  - Boland A

AU  - Duarte R

AU  - Kotas E

AU  - Woolacott N

AU  - Hodgson R

AU  - Riemsma R

AU  - Grimm S

AU  - Ramaekers B

AU  - Joore M

AU  - Büyükkaramikli N et al

ED  - 

DO  - DOI: 10.1007/s40258-018-0393-7

PB  - Springer Nature

VL  - 16

IS  - 4

SP  - 429

EP  - 432

Y2  - 2025/10/31

ER  -